191 related articles for article (PubMed ID: 11344298)
1. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands.
Tocchini-Valentini G; Rochel N; Wurtz JM; Mitschler A; Moras D
Proc Natl Acad Sci U S A; 2001 May; 98(10):5491-6. PubMed ID: 11344298
[TBL] [Abstract][Full Text] [Related]
2. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket.
Molnár F; Peräkylä M; Carlberg C
J Biol Chem; 2006 Apr; 281(15):10516-26. PubMed ID: 16478719
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.
Rochel N; Wurtz JM; Mitschler A; Klaholz B; Moras D
Mol Cell; 2000 Jan; 5(1):173-9. PubMed ID: 10678179
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
[TBL] [Abstract][Full Text] [Related]
8. Ligand-specific structural changes in the vitamin D receptor in solution.
Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
[TBL] [Abstract][Full Text] [Related]
9. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
Yamamoto K; Anami Y; Itoh T
Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
[TBL] [Abstract][Full Text] [Related]
10. Structural changes of vitamin D receptor induced by 20-epi-1alpha,25-(OH)2D3: an insight from a computational analysis.
Sicinska W; Rotkiewicz P
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):253-8. PubMed ID: 19429430
[TBL] [Abstract][Full Text] [Related]
11. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
12. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
[TBL] [Abstract][Full Text] [Related]
13. Ligand recognition by the vitamin D receptor.
Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
15. Structurally and functionally important amino acids of the agonistic conformation of the human vitamin D receptor.
Väisänen S; Ryhänen S; Saarela JT; Peräkylä M; Andersin T; Mäenpää PH
Mol Pharmacol; 2002 Oct; 62(4):788-94. PubMed ID: 12237325
[TBL] [Abstract][Full Text] [Related]
16. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.
Zhang J; Chalmers MJ; Stayrook KR; Burris LL; Garcia-Ordonez RD; Pascal BD; Burris TP; Dodge JA; Griffin PR
Structure; 2010 Oct; 18(10):1332-41. PubMed ID: 20947021
[TBL] [Abstract][Full Text] [Related]
18. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
Ciesielski F; Rochel N; Moras D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
[TBL] [Abstract][Full Text] [Related]
19. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
Quack M; Carlberg C
J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
[TBL] [Abstract][Full Text] [Related]
20. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
Ikura T; Ito N
Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]